These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. PAR1 signaling: more good than harm? Ruf W Nat Med; 2003 Mar; 9(3):258-60. PubMed ID: 12612568 [No Abstract] [Full Text] [Related]
7. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation. Burke FM; Warnock M; Schmaier AH; Mosberg HI Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882 [TBL] [Abstract][Full Text] [Related]
8. [Study of thrombomodulin and its significance]. Zhang HY Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):323-7. PubMed ID: 1338808 [No Abstract] [Full Text] [Related]
9. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Vretenbrant K; Ramström S; Bjerke M; Lindahl TL Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509 [TBL] [Abstract][Full Text] [Related]
10. The interaction of thrombin with blood platelets. Lundblad RL; White GC Platelets; 2005 Nov; 16(7):373-85. PubMed ID: 16236598 [TBL] [Abstract][Full Text] [Related]
11. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies. Ahrens I; Peter K Thromb Haemost; 2008 May; 99(5):803-4. PubMed ID: 18449408 [No Abstract] [Full Text] [Related]
14. Coagulation and fibrosis in chronic liver disease. Calvaruso V; Maimone S; Gatt A; Tuddenham E; Thursz M; Pinzani M; Burroughs AK Gut; 2008 Dec; 57(12):1722-7. PubMed ID: 19022928 [TBL] [Abstract][Full Text] [Related]
15. Development of platelet contractile force as a research and clinical measure of platelet function. Carr ME Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942 [TBL] [Abstract][Full Text] [Related]
16. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Isermann B; Sood R; Pawlinski R; Zogg M; Kalloway S; Degen JL; Mackman N; Weiler H Nat Med; 2003 Mar; 9(3):331-7. PubMed ID: 12579195 [TBL] [Abstract][Full Text] [Related]
17. Thrombin and vascular development: a sticky subject. Moser M; Patterson C Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):922-30. PubMed ID: 12807713 [TBL] [Abstract][Full Text] [Related]
18. A laboratory method for parallel determination of platelet aggregation and thrombin generation. Köstenberger M; Gallistl S; Cvirn G; Muntean W Clin Lab; 2004; 50(1-2):41-8. PubMed ID: 15000219 [TBL] [Abstract][Full Text] [Related]
19. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179 [TBL] [Abstract][Full Text] [Related]
20. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists. Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]